The fund will be jointly managed by Pradeep Gokhale and Rohan Korde. The minimum amount of the request is Rs 5,000 and in multiples of Re 1 thereafter.

As the name suggests, the fund will invest in the pharmaceutical and healthcare sectors and will be compared to the Nifty Healthcare Total Return index.

“The Covid-19 pandemic has given new impetus to the Indian pharmaceutical sector. ITI Pharma and Healthcare Fund believe in providing a unique investment experience to their investors by adopting diligent and research-backed investment processes, ”said George Heber Joseph, CEO and Chief Investment Officer, ITI Mutual Fund.

“The fund company follows SQL’s investment philosophy – Safety Margin, Company Quality and Low Leverage and provides a superior investment experience to its investors,” he added.

ITI Mutual Fund started operations in April 2019 and has launched 13 traditional mutual fund products since then.

The fund house crossed Rs 2,000 crore AUM in August 2021 this year.

Of the total of Rs 2,034 crore as of August 31, 2021, assets under management of equity amounted to Rs 1,460 crore, while hybrid and debt plans were Rs 230 crore and Rs 344 crore respectively.